Max Robotics — Global Service Robot Directory + US Certification

About

Byoung Chul Cho is a pioneering surgeon whose work has redefined the boundaries of robotic surgery in head and neck oncology. His research centers on the integration of transoral robotic surgery (TORS) into multimodal treatment paradigms for advanced-stage cancers. Cho’s landmark 2017 study on stage III-IV oropharyngeal squamous cell carcinoma (36 citations) demonstrated that TORS-based therapy can achieve oncologic control while preserving critical functions, challenging the traditional reliance on chemoradiation. He further expanded the indications for robotic surgery in a 2017 clinical trial (26 citations) exploring neoadjuvant chemotherapy combined with TORS for T3 and T4 laryngo-hypopharyngeal cancer, a notoriously difficult-to-treat population. Beyond the head and neck, Cho has contributed to urologic oncology, as seen in his 2012 work on robot-assisted laparoscopic radical cystectomy with orthotopic neobladder formation (5 citations), where he refined surgical techniques to improve patient outcomes. With a career spanning both early adoption and rigorous clinical validation of robotic platforms, Cho’s work has directly influenced treatment guidelines, offering patients less invasive options without compromising survival. His research continues to shape the future of precision surgery in cancer care.